Robertson Stephens Wealth Management, LLC reports 0.44% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Robertson Stephens Wealth Management, LLC
Latest Disclosed Ownership	43,070 shares
Latest Disclosed Value	$ 2,612,200

On April 28, 2026 - Robertson Stephens Wealth Management, LLC filed a 13F-HR form disclosing ownership of 43,070 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,257,729 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 42,881 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.44% during the quarter. The current value of the position is $2,042,810 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-28	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	43,070	189	0.44	2,612	12.93	0.0732
2026-02-02	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	42,881	32,059	296.24	2,313	373.98	0.0603
2025-11-12	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,822	426	4.10	488	1.46	0.0147
2025-07-24	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,396	1,205	13.11	481	-14.11	0.0153
2025-04-17	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,191	-963	-9.48	561	-2.44	0.0193
2025-01-27	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,154	-262	-2.52	574	6.69	0.0203
2024-11-12	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,416	-376	-3.48	539	20.09	0.0195
2024-08-13	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,792	-1,197	-9.98	448	-31.08	0.0226
2024-05-15	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,989	216	1.83	650	7.62	0.0345
2024-02-06	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,773	-5,234	-30.78	604	-38.80	0.0367
2023-11-13	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	17,007	-1,516	-8.18	987	-16.64	0.0666
2023-08-11	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	18,523	-2,379	-11.38	1,185	-18.23	0.0838
2023-05-11	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,902	-1,073	-4.88	1,449	-8.41	0.1115
2023-02-14	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,975	-1,239	-5.34	1,581	-4.18	0.1540
2022-11-14	2022-09-30	13F	Bristol Myers Squibb	COM	110122108	23,214	785	3.50	1,650	-5.12	0.1722
2022-08-12	2022-06-30	13F	Bristol Myers Squibb	COM	110122108	22,429	700	3.22	1,739	8.82	0.1640
2022-05-16	2022-03-31	13F	Bristol Myers Squibb	COM	110122108	21,729	-160	-0.73	1,598	17.16	0.1342
2022-02-14	2021-12-31	13F	Bristol Myers Squibb	COM	110122108	21,889	10,899	99.17	1,364	108.24	0.1147
2021-11-10	2021-09-30	13F	Bristol Myers Squibb	COM	110122108	10,990	-1,813	-14.16	655	-23.39	0.0740
2021-08-17	2021-06-30	13F	Bristol Myers Squibb	COM	110122108	12,803	1,507	13.34	855	19.08	0.1027
2021-05-07	2021-03-31	13F	Bristol Myers Squibb	COM	110122108	11,296	6,301	126.15	718	130.13	0.1148
2021-02-10	2020-12-31	13F	Bristol Myers Squibb	COM	110122108	4,995	-308	-5.81	312	-2.19	0.0652
2020-11-10	2020-09-30	13F	Bristol Myers Squibb	COM	110122108	5,303	42	0.80	319	3.24	0.0784
2020-08-12	2020-06-30	13F	Bristol Myers Squibb	COM	110122108	5,261	324	6.56	309	12.36	0.0892
2020-05-01	2020-03-31	13F	Bristol Myers Squibb	COM	110122108	4,937	4,937		275		0.0939

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.